8RZ9 | pdb_00008rz9

MutSbeta-ATPgS with kinked MSH2 clamp


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.02 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation 3D Report Full Report

Validation slider image for 8RZ9

This is version 1.1 of the entry. See complete history

Literature

Elucidation of multiple high-resolution states of human MutS beta by cryo-EM reveals interplay between ATP/ADP binding and heteroduplex DNA recognition.

Lee, J.H.Thomsen, M.Daub, H.Thieulin-Pardo, G.Steinbacher, S.Sztyler, A.Dahiya, V.Neudegger, T.Dominguez, C.Iyer, R.R.Wilkinson, H.A.Monteagudo, E.Plotnikov, N.V.Felsenfeld, D.P.Haque, T.S.Finley, M.Boudet, J.Vogt, T.F.Prasad, B.C.

(2025) Nucleic Acids Res 53

  • DOI: https://doi.org/10.1093/nar/gkaf604
  • Primary Citation Related Structures: 
    8OLX, 8OM5, 8OM9, 8OMA, 8OMO, 8OMQ, 8RZ7, 8RZ8, 8RZ9

  • PubMed Abstract: 

    Human and mouse genetic studies have demonstrated a role for DNA mismatch repair (MMR) molecular machines in modulating the rate of somatic expansion of the huntingtin (HTT) CAG repeats, and onset and progression of Huntington's Disease (HD). MutSβ, a key component of the MMR pathway, is a heterodimeric protein of MSH2 and MSH3 that recognizes and initiates the repair of extrahelical DNA extrusions. Loss-of-function of mouse Msh3 and reduced-expression alleles of human MSH3 lead to slower rates of somatic expansion and delayed disease onset in humans, signifying MSH3 as a promising therapeutic target for HD. Here we report biochemical and cryo-electron microscopy analyses of human MutSβ, demonstrating MutSβ undergoes conformational changes induced by nucleotide and DNA binding. We present multiple conformations of MutSβ including the DNA-free MutSβ compatible with precisely complementary base-paired homoduplex DNA binding, two distinct structures of MutSβ bound to (CAG)2 DNA, a sliding clamp form and a DNA-unbound, ATP-bound conformation. Along with evidence for novel conformational states adopted by MutSβ to initiate the MMR cascade, these structures provide a foundation for structure-guided drug discovery.


  • Organizational Affiliation
    • Proteros biostructures GmbH, Bunsenstr 7a, Martinsried, 82152, Germany.

Macromolecule Content 

  • Total Structure Weight: 233.58 kDa 
  • Atom Count: 8,571 
  • Modeled Residue Count: 1,067 
  • Deposited Residue Count: 2,071 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
DNA mismatch repair protein Msh2934Homo sapiensMutation(s): 0 
Gene Names: MSH2
UniProt & NIH Common Fund Data Resources
Find proteins for P43246 (Homo sapiens)
Explore P43246 
Go to UniProtKB:  P43246
PHAROS:  P43246
GTEx:  ENSG00000095002 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP43246
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
DNA mismatch repair protein Msh31,137Homo sapiensMutation(s): 0 
Gene Names: MSH3DUC1DUG
UniProt & NIH Common Fund Data Resources
Find proteins for P20585 (Homo sapiens)
Explore P20585 
Go to UniProtKB:  P20585
PHAROS:  P20585
GTEx:  ENSG00000113318 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP20585
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.02 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
CHDI FoundationUnited States--

Revision History  (Full details and data files)

  • Version 1.0: 2024-11-13
    Type: Initial release
  • Version 1.1: 2026-05-27
    Changes: Data collection, Database references